Ignite Creation Date:
2024-05-05 @ 11:40 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00109538
Status:
TERMINATED
Last Update Posted:
2015-05-01
First Post:
2005-04-28
Brief Title:
Study of Lonafarnib Versus Placebo in Subjects With Either Myelodysplastic Syndrome MDS or Chronic Myelomonocytic Leukemia CMML Study P02978AM3TERMINATED
Sponsor:
Merck Sharp Dohme LLC
Organization:
Merck Sharp Dohme LLC
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-05
Start Date Type:
None
Primary Completion Date:
2008-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-08
Completion Date Type:
ACTUAL
First Submit Date:
2005-04-28
First Submit QC Date:
April 28 2005
Study First Post Date:
2005-04-29
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2009-04-14
Disp First Submit QC Date:
October 16 2009
Disp First Post Date:
2009-10-20
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2015-04-09
Last Update Post Date:
2015-05-01
Last Update Post Date Type:
ESTIMATED